ZETONNIA MILBURN: Open Payments
NPI 1649852609 · GAUTIER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 12 payments from 5 companies in 2025. Trend: 2023 $991 · 2024 $901 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $111 |
| Janssen Pharmaceuticals, Inc | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: COBENFY, INVEGA SUSTENNA, UZEDY, FANAPT, ABILIFY ASIMTUFII.
Industry payments across MS — which companies pay providers there.
